Evidence map›Paper›PMID 34116719›Full record

ArticleJournal of pharmaceutical policy and practice2021

A cross-sectional survey on community pharmacists readiness to fight COVID-19 in a developing country: knowledge, attitude, and practice in Lebanon.

Rony M Zeenny, Ahmad Dimassi, Hala Sacre, Ghada El Khoury, Aline Hajj, Rita Farah, Hind Hajj, Nathalie Lahoud, Marwan Akel, Souheil Hallit and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Evaluation of patient safety culture in community pharmacies.Exploratory research in clinical and social pharmacy · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Rony M Zeenny *Pharmacy Department, American University of Beirut Medical Center, Beirut, Lebanon.
Ahmad Dimassi *School of Pharmacy, Lebanese International University, Beirut, Lebanon.
Hala SacreINSPECT-LB: Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie, Beirut, Lebanon.
Ghada El KhourySchool of Pharmacy, Lebanese American University, Byblos, Lebanon.
Aline HajjFaculty of Pharmacy, Saint-Joseph University, Beirut, Lebanon.
Rita FarahINSPECT-LB: Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie, Beirut, Lebanon.
Hind HajjSchool of Pharmacy, Lebanese International University, Beirut, Lebanon.
Nathalie LahoudINSPECT-LB: Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie, Beirut, Lebanon.
Marwan AkelSchool of Pharmacy, Lebanese International University, Beirut, Lebanon.
Souheil HallitINSPECT-LB: Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie, Beirut, Lebanon. souheilhallit@hotmail.com.ORCID http://orcid.org/0000-0001-6918-5689
Pascale SalamehINSPECT-LB: Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie, Beirut, Lebanon.
Lebanese International University · LBLebanese University · LBAmerican University of Beirut Medical Center · LBHoly Spirit University of Kaslik · LBLebanese American University · LBSaint Joseph University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLebanon, a developing Middle Eastern country, was hit by the COVID-19 pandemic that occurred amid a severe national economic crisis. Community pharmacists are responsible for dispensing appropriate medications and products in addition to counseling, informing and educating the public, and promoting disease prevention and infection control.

objectiveThis study aimed to assess community pharmacists' knowledge, attitude, and practice towards the COVID-19 pandemic and evaluate behavior changes and safety measures.

methodsAn anonymous and standardized online questionnaire in English was disseminated via social media platforms to Lebanese community pharmacists. The questionnaire consisted of 95 items designed as Likert-scales and multiple-choice questions divided into four different sections: socio-demographic characteristics, knowledge-based, attitude-based, and pharmacy practice questions. Descriptive statistical analysis was used to summarize the demographic characteristics, and indices were created for knowledge, attitude, and practice by computing the correct answers for each section.

resultsA total of 310 questionnaires were completed. Around 61% have expressed their fear of getting infected with COVID-19 due to occupational exposure. The respondents were able to answer 80-90% of the knowledge-based questions of the survey. A more careful/anxious attitude, but not knowledge, was associated with overall better practice (p = 0.03). Also, respondents stated that they are dispensing protective equipment items such as masks (87%), gloves (60%), and sanitizers (77%) in small quantities due to limited availability.

conclusionOur findings revealed an adequate level of knowledge and good practice towards COVID-19 among Lebanese community pharmacists. Their fears of contracting the virus and compromising the safety of those around them are justified. However, their supply of protective equipment is limited.

Indexed as

AttitudeCommunity pharmacyCOVID-19KnowledgePatient servicePracticeProtective measures

Identifiers

PMID34116719
PMCPMC8193173
OpenAlexW3171508690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.